CATHERINE GANNON: Open Payments
NPI 1568013316 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,520 in 74 payments from 29 companies in 2025. Trend: 2023 $490 · 2024 $901 · 2025 $1,520
Food & beverage: $1,520
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $227 |
| Biogen, Inc. | 10 | $211 |
| UCB, Inc. | 5 | $167 |
| Janssen Biotech, Inc. | 2 | $69 |
| Neurocrine BioSciences, Inc. | 2 | $60 |
| ARGENX US, INC. | 2 | $59 |
| Lundbeck LLC | 2 | $55 |
| Eisai Inc. | 2 | $54 |
| Celgene Corporation | 3 | $52 |
| Lilly USA, LLC | 2 | $51 |
Products named: Rystiggo, QULIPTA, VUMERITY, UBRELVY, INGREZZA, VYEPTI, Leqembi, ZEPOSIA.
Industry payments across MD — which companies pay providers there.
